BG Medicine Outlines New Commercial Strategy

BG Medicine Outlines New Commercial Strategy

[at noodls] – WALTHAM, Mass., Nov. 13, 2012 (GLOBE NEWSWIRE) — BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, today provided an update … more

View todays social media effects on BGMD

View the latest stocks trending across Twitter. Click to view dashboard

Share this post